SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-157556
Filing Date
2021-05-11
Accepted
2021-05-11 16:00:52
Documents
3
Period of Report
2021-05-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d24470d8k.htm 8-K 19349
2 EX-3.1 d24470dex31.htm EX-3.1 39914
3 EX-3.2 d24470dex32.htm EX-3.2 114783
  Complete submission text file 0001193125-21-157556.txt   175213
Mailing Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202
Business Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202 502-569-1059
Talaris Therapeutics, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40384 | Film No.: 21911175
SIC: 2836 Biological Products, (No Diagnostic Substances)